Conclusions
Schisantherin A (Sch A) exhibits diverse pharmacological effects, including anti-Parkinson, anti-inflammatory, hepatoprotective, anti-ischemia-reperfusion injury, anti-osteoclast formation, and cognitive enhancement properties. Its mechanism of action involves antioxidant, anti-inflammatory, and antiapoptotic pathways mediated by MAPK, NF-κB, AKT/GSK3β, and PI3K/AKT pathways.